Role of tumor mutational burden (TMB) and microsatellite instability (MSI) in patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitor (ICI)

被引：0
|
作者：
Bakaloudi, Dimitra Rafailia
Talukder, Rafee
Makrakis, Dimitrios
Diamantopoulos, Leonidas Nikolaos
Patgunarajah, Ubenthira
Thomas, Vinay Mathew
Jindal, Tanya
Brown, Jason R.
Miletic, Marija
Johnson, Jeffrey
Hui, Gavin
Buznego, Lucia Alonso
Morales-Barrera, Rafael
Castaneda, David Humberto Marmolejo
Nguyen, Charles B.
Barata, Pedro C.
Stewart, Tyler F.
Gupta, Shilpa
Grivas, Petros
Khaki, Ali Raza
机构：
[1] Univ Washington, Dept Med, Div Oncol, Seattle, WA USA
[2] Baylor Coll Med, Houston, TX USA
[3] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY USA
[4] Mayo Clin, Rochester, MN USA
[5] Cleveland Clin, Cleveland, OH USA
[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[7] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[8] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[9] Univ Hosp Ctr Sisters Mercy, Zagreb, Croatia
[10] Univ Iowa, Dept Med, Div Oncol, Iowa City, IA USA
[11] Univ Calif Los Angeles, Los Angeles, CA USA
[12] Hosp Univ Marques de Valcecilla, Santander, Spain
[13] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[14] Vall dHebron Univ Hosp, Barcelona, Spain
[15] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[16] Univ Calif San Diego Hlth, La Jolla, CA USA
[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[18] Univ Washington, Div Hematol & Oncol, Seattle, WA USA
[19] Fred Hutchinson Canc Ctr, Seattle, WA USA
[20] Stanford Univ, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：654 / 654
页数：1
相关论文
共 50 条
  • [1] Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Inhibitor
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Makrakis, Dimitrios
    Diamantopoulos, Leonidas
    Enright, Thomas
    Leary, Jacob B.
    Patgunarajah, Ubenthira
    Thomas, Vinay M.
    Swami, Umang
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Brown, Jason R.
    Barata, Pedro
    Murgic, Jure
    Miletic, Marija
    Johnson, Jeffrey
    Zakharia, Yousef
    Hui, Gavin
    Drakaki, Alexandra
    Duran, Ignacio
    Buznego, Lucia A.
    Barrera, Rafael M.
    Castaneda, David M.
    Rey-Cardenas, Macarena
    Castellano, Daniel
    Nguyen, Charles B.
    Park, Joseph J.
    Alva, Ajjai
    McKay, Rana R.
    Stewart, Tyler F.
    Epstein, Ilana B.
    Bellmunt, Joaquim
    Wright, Jonathan L.
    Gupta, Shilpa
    Grivas, Petros
    Khaki, Ali Raza
    [J]. CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [2] Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
    Talukder, Rafee
    Bakaloudi, Dimitra Rafailia
    Lin, Genevieve Ihsiu
    Enright, Tom
    Leary, Jacob Beck
    Makrakis, Dimitrios
    Tripathi, Nishita
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Brown, Jason R.
    Johnson, Jeffrey
    Zakharia, Yousef
    Park, Joseph J.
    Alva, Ajjai Shivaram
    Barrera, Rafael Morales
    Drakaki, Alexandra
    Barata, Pedro C.
    Khaki, Ali Raza
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) as predictive biomarkers for immune checkpoint inhibitor (ICI) effectiveness in real-world patients with metastatic colorectal cancer (mCRC).
    Ellis, Haley
    Klempner, Samuel J.
    Quintanilha, Julia C. F. C. F.
    Myer, Parvathi
    Lin, Douglas I.
    Panarelli, Nicole
    Fisher, Virginia
    Li, Gerald
    Huang, Richard S. P.
    Ross, Jeffrey S.
    Oxnard, Geoffrey R.
    Graf, Ryon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 46 - 46
  • [4] Enfortumab vedotin (EV) outcomes with and without immediate prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial carcinoma (aUC).
    Koshkin, Vadim S.
    Henderson, Nicholas
    Kilari, Deepak
    Jindal, Tanya
    Alhalabi, Omar
    Freeman, Dory
    Basu, Arnab
    Barata, Pedro C.
    Bilen, Mehmet Asim
    Zakharia, Yousef
    Emamekhoo, Hamid
    Shah, Sumit
    Milowsky, Matthew I.
    Davis, Nancy B.
    Gupta, Shilpa
    Hoimes, Christopher J.
    Grivas, Petros
    Bellmunt, Joaquim
    Campbell, Matthew T.
    Alva, Ajjai Shivaram
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] Outcomes of enfortumab vedotin (EV) therapy in relation to prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial cancer (aUC).
    Vlachou, Evangelia
    Elias, Roy
    Hahn, Noah M.
    Mcconkey, David James
    Johnson, Burles Avner
    Hoffman-Censits, Jean H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 570 - 570
  • [6] Outcomes with immune checkpoint inhibitor (ICI) therapy in patients with FGFR2/3 alterations in advanced urothelial carcinoma (aUC).
    Talukder, Rafee
    Bakaloudi, Dimitra Rafailia
    Makrakis, Dimitrios
    Tripathi, Nishita
    Agarwal, Neeraj
    Jindal, Tanya
    Koshkin, Vadim S.
    Johnson, Jeffrey
    Zakharia, Yousef
    Brown, Jason
    Rey-Cardenas, Macarena
    Castellano, Daniel
    Alva, Ajjai Shivaram
    Zakopoulou, Roubini
    Korolewicz, James
    Drakaki, Alexandra
    Barata, Pedro C.
    Grivas, Petros
    Khaki, Ali Raza
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Histologic subtype and response to immune checkpoint inhibitor (ICI) therapy in advanced urothelial cancer (aUC)
    Miller, Natalie J.
    Khaki, Ali Raza
    Diamantopoulos, Leonidas Nikolaos
    Bilen, Mehmet Asim
    Santos, Victor Sacristan
    Morales-Barrera, Rafael
    Devitt, Michael Edward
    Nelson, Ariel Ann
    Shreck, Evan
    Assi, Hussein
    Rodriguez-Vida, Alejo
    Lythgoe, Mark
    Drakaki, Alexandra
    Joshi, Monika
    Velho, Pedro Isaacsson
    Moses, Marcus W.
    Galsky, Matt D.
    Sonpavde, Guru
    Yu, Evan Y.
    Grivas, Petros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Association between sites of metastases (mets) and outcomes with immune checkpoint inhibitor (ICI) therapy for advanced urothelial carcinoma (aUC).
    Makrakis, Dimitrios
    Diamantopoulos, Leonidas Nikolaos
    Koshkin, Vadim S.
    Alva, Ajjai Shivaram
    Bilen, Mehmet Asim
    Stewart, Tyler Francis
    Santos, Victor Sacristan
    Jain, Jayanshu
    Morales-Barrera, Rafael
    Devitt, Michael E.
    Carril-Ajuria, Lucia
    Nelson, Ariel Ann
    Sankin, Alexander
    Zakopoulou, Roubini
    Pinato, David James
    Frobe, Ana
    Joshi, Monika
    Sonpavde, Guru
    Grivas, Petros
    Khaki, Ali Raza
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Tumor mutational burden (TMB) in immune checkpoint inhibitor (ICI)-naive and -experienced patients with metastatic melanoma treated with lifileucel, a tumorinfiltrating lymphocyte (TIL) cell therapy.
    Kluger, Harriet M.
    Sarnaik, Amod
    Chesney, Jason Alan
    Lewis, Karl D.
    Weber, Jeffrey S.
    Gogas, Helen
    In, Gino Kim
    Terheyden, Patrick Andres Maximilian
    Lee, Sylvia
    Jagasia, Madan H.
    Masteller, Emma
    Qi, Rongsu
    Gontcharova, Viktoria
    Shi, Wen
    Fiaz, Rana
    Sulur, Giri
    Wu, Renee Xiao
    Chen, Guang
    Thomas, Sajeve Samuel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer
    Lenis, Andrew T.
    Ravichandran, Vignesh
    Brown, Samantha
    Alam, Syed M.
    Katims, Andrew
    Truong, Hong
    Reisz, Peter A.
    Vasselman, Samantha
    Nweji, Barbara
    Autio, Karen A.
    Morris, Michael J.
    Slovin, Susan F.
    Rathkopf, Dana
    Danila, Daniel
    Woo, Sungmin
    Vargas, Hebert A.
    Laudone, Vincent P.
    Ehdaie, Behfar
    Reuter, Victor
    Arcila, Maria
    Berger, Michael F.
    Viale, Agnes
    Scher, Howard I.
    Schultz, Nikolaus
    Gopalan, Anuradha
    Donoghue, Mark T. A.
    Ostrovnaya, Irina
    Stopsack, Konrad H.
    Solit, David B.
    Abida, Wassim
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3894 - 3903
12345